Tag: <span>Manuel Bigler</span>

Europe Legal Chronicle. July 13, 2023

Merck’s Win Commercial Contract Litigation in Canton Of Zurich Court

By Marco Zingaro

Walder Wyss represents Merck in the Swiss proceedings. The Federal Supreme Court confirms far-reaching injunctions granted in favor of the German science and technology company Merck...

This content is for Standard 1 Year members only.
Login Join Now

Europe Legal Chronicle. April 21, 2023

Alentis Therapeutics’ $105 Million Series C Funding Round

By Pietro Martinoia

Walder Wyss advises Alentis Therapeutics on the financing. Alentis Therapeutics has announced $105 million in Series C financing. The funding round was led by Jeito Capital...

This content is for Standard 1 Year members only.
Login Join Now

Europe Legal Chronicle. November 4, 2022

Intel 471’s Acquisition of SpiderFoot

By Federica Tiefenthaler

Walder Wyss and TGS Baltics advised the selling founder as lead counsel. Magnusson advised the acquirer Intel 471 in-cooperation with Loyens & Loeff (Switzerland), Reed Smith...

This content is for Standard 1 Year members only.
Login Join Now

Europe Legal Chronicle. October 4, 2022

Cembra Money Bank’s CHF 60 Million Acquisition of Byjuno and Intrum Finance Services

By Federica Tiefenthaler

Pestalozzi advised Intrum on the deal. Walder Wyss has advised Cembra on the transaction. Byjuno was founded by Intrum AG in 2014 and is one of...

This content is for Standard 1 Year members only.
Login Join Now

Europe Legal Chronicle. August 26, 2022

Vector BioPharma’s USD 30 Million Series A Funding Round

By Federica Tiefenthaler

Walder Wyss advised Versant Ventures on the deal. Versant Ventures announced the debut of Vector BioPharma, a biopharmaceutical company developing a precision gene delivery platform that...

This content is for Standard 1 Year members only.
Login Join Now

Europe. Europe Legal Chronicle. June 18, 2021

Alentis Therapeutics’ $67 Million Series B Financing Round

By Federica Tiefenthaler

Walder Wyss advised Alentis Therapeutics AG on the deal. Alentis Therapeutics AG announced a USD 67m series B financing round. Morningside Venture Investments led the financing, joined...

This content is for Standard 1 Year members only.
Login Join Now

Charles River’s Collaboration with Related Sciences

Otsuka’s Collaboration with ShapeTX

Enovix’s Acquisition of Routejade

Agrotecnología Sala’s US$1.4 Million Notes Issuance

MercadoLibre’s US$17.9 Million Financial Trust Issuance

Connectly’s US$7.8 Million Financing Round

Cortus Energy’s Rights Offering

Yubico’s Shares Placement

Logistea’s Rights Offering

Post For Investment’s Acquisition of Roaderz Technologies

YANMU Logistics Park’s Financing Agreement with CIB

Beltone’s Share Purchase Agreement with Cash

Panaxia Labs Israel’s Share Swap Agreement with the Barak Group

Menora Mivtachim’s Public Offering

International Schools Partnership’s Acquisition of The English College

Umami United’s Investment Round

K2 Partnering Solutions’ Acquisition of Openlogix

Asia Healthcare Holdings’ Acquisition of Majority Stake in Asian Institute of Nephrology and Urology

Braden McCurrach Joins Jones Day as Partner in Corporate Practice

stevensdrake Welcomes Nusrat Qureishi as Head of Corporate and Commercial Law, Associate Director

Polsinelli Continues Corporate Growth Momentum With Two New Shareholders in St. Louis

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Presumption of “Tax Inversion”: The Italian Supreme Court Clarifues That “Mediated” Control Is Not Relevant

Braden McCurrach Joins Jones Day as Partner in Corporate Practice

stevensdrake Welcomes Nusrat Qureishi as Head of Corporate and Commercial Law, Associate Director

Polsinelli Continues Corporate Growth Momentum With Two New Shareholders in St. Louis

Manuel Bigler

Merck’s Win Commercial Contract Litigation in Canton Of Zurich Court

ITS Kanal Services AG’s Acquisition of Restclean AG

Alentis Therapeutics’ $105 Million Series C Funding Round

Intel 471’s Acquisition of SpiderFoot

Cembra Money Bank’s CHF 60 Million Acquisition of Byjuno and Intrum Finance Services

Vector BioPharma’s USD 30 Million Series A Funding Round

Alentis Therapeutics’ $67 Million Series B Financing Round